Agilent Technologies Stock News

Major analytical techniques currently used in metabolomics include NMR, Fourier transform infrared spectroscopy, gas chromatography mass spectrometry (GC-MS), LC-MS and capillary electrophoresismass spectrometry. H-NMR is the most often used technique, although 31P-NMR and 13C-NMR can be applied as well. The most

The Oncology Molecular Diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell

Agilent Technologies, Inc. (NYSE:A) Equities researchers at Jefferies Financial Group raised their Q1 2022 earnings estimates for shares of Agilent Technologies in a report issued on Tuesday, November 23rd. Jefferies Financial Group analyst B. Couillard now forecasts that the medical research company will post earnings per share of $1.18 for the quarter, up from []

Agilent Technologies (NYSE:A) had its price target lifted by Stifel Nicolaus from $162.00 to $169.00 in a research note published on Tuesday, Price Targets.com reports. Stifel Nicolaus currently has a hold rating on the medical research companys stock. A number of other research analysts have also recently commented on the company. KeyCorp increased their target []

Next Generation Cancer Diagnostics market research report serves a lot of parameters and detailed data about healthcare industry. The report endows with the steadfast knowledge and information of revolutionizing market landscape, what already exists in the market, future trends or

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to present at Evercore ISI Virtual Healthcare Conference.

The

IFM Investors Pty Ltd trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,589 shares of the medical research companys stock after selling 182 shares during the period. IFM Investors Pty Ltds []

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent to present at Evercore ISI Virtual Healthcare Conference.

Agilent Technologies' (A) fourth-quarter fiscal 2021 results reflect a solid end-market momentum and strong growth across Americas and China.

An international Gastric Cancer Diagnostics Market 2021 report makes available an overview of the Gastric Cancer Diagnostics industry which is gaining momentum in the last few years. This report covers a detailed study of the Gastric Cancer Diagnostics Market size,

Agilent Technologies (NYSE:A) issued an update on its FY22 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $4.76-4.86 for the period, compared to the Thomson Reuters consensus estimate of $4.78. The company issued revenue guidance of $6.65-6.73 billion, compared to the consensus revenue estimate of $6.75 billion.Agilent Technologies also []

Agilent Technologies (NYSE:A) posted its earnings results on Monday. The medical research company reported $1.21 EPS for the quarter, beating analysts consensus estimates of $1.18 by $0.03, MarketWatch Earnings reports. The firm had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.66 billion. Agilent Technologies had a return on equity []